Immudex’ coverbillede
Immudex

Immudex

Forskning inden for bioteknologi

Copenhagen, Capital Region 6.983 følgere

Decipher Adaptive Immunity

Om os

Immudex is a life science company and trusted partner of scientists spearheading the global adoption of precision immune monitoring. Immudex’s Dextramer® technology enables superior detection of antigen-specific immune cells. Immudex’s product portfolio allows scientists to investigate diverse types of immune cells, including T cells, non-conventional T cells, B cells and CAR cells using flow cytometry, next generation sequencing and single-cell multi-omics.

Branche
Forskning inden for bioteknologi
Virksomhedsstørrelse
11-50 medarbejdere
Hovedkvarter
Copenhagen, Capital Region
Type
Privat
Grundlagt
2009
Specialer
Flow cytometry, Single-cell Multi-omics, Immune Monitoring, CAR cell detection and characterization, Antigen-specific T and B cells, Non-conventional T cells, MHC multimers, Dextramer® Technology, CAR Dextramer®, T cell stimulation, GMP reagents, Klickmer® Technology, TCR discovery, U-Load Dextramer®, dCODE Dextramer®, MHC Monomers, MAIT cells, iNKT cells, TCR Dextramer®, Soluble TCR Monomers, Custom Solutions & Services, pMHC Binding Screening Service og Custom allele development

Beliggenheder

  • Primær

    Bredevej 2A

    Copenhagen, Capital Region 2830, DK

    Se ruten
  • 3675 Market St

    Suite 200

    Philadelphia, Pennsylvania 19104, US

    Se ruten

Medarbejdere hos Immudex

Opdateringer

Tilsvarende sider